Susquehanna International Group, LLP Xenon Pharmaceuticals Inc. Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$36.12 - $43.96 $97,524 - $118,692	-2,700 Reduced 25.23%	8,000 $314,000
Q2 2024 Aug 15, 2024	BUY	$36.25 - $43.75 $387,875 - $468,125	10,700 New	10,700 $417,000
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $441,980 - $715,484	-15,400 Reduced 43.02%	20,400 $939,000
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $119,559 - $139,055	3,500 Added 10.84%	35,800 $1.22 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $620,152 - $775,012	17,800 Added 122.76%	32,300 $1.24 Million
Q1 2023 May 16, 2023	BUY	$33.46 - $40.35 $247,604 - $298,590	7,400 Added 104.23%	14,500 $518,000
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $869,478 - $1.04 Million	-26,300 Reduced 78.74%	7,100 $279,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $723,565 - $935,770	23,500 Added 237.37%	33,400 $1.21 Million
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $83,952 - $116,027	-3,300 Reduced 25.0%	9,900 $301,000
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $1.35 Million - $1.78 Million	-53,700 Reduced 80.27%	13,200 $404,000
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $1.35 Million - $3.06 Million	-86,500 Reduced 56.39%	66,900 $2.09 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $2.28 Million - $2.98 Million	153,400 New	153,400 $2.34 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.